Juan Francisco Fernández-González Selected Research

L 694247

5/2022

Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Francisco Fernández-González Research Topics

Disease

2	Body Weight (Weight, Body) 09/2022 - 03/2022
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022 - 03/2022
1	Polydipsia 09/2022
1	Hyperglycemia 09/2022
1	Polyuria 09/2022
1	Bradycardia 05/2022
1	Diabetes Complications 05/2022

Drug/Important Bio-Agent (IBA)

3	Serotonin (5 Hydroxytryptamine)IBA 09/2022 - 03/2022
2	Fluoxetine (Prozac)FDA LinkGeneric 05/2022 - 03/2022
1	Blood Glucose (Blood Sugar)IBA 09/2022
1	Serotonin ReceptorsIBA 09/2022
1	sarpogrelateIBA 09/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2022
1	Antidepressive Agents (Antidepressants)IBA 05/2022
1	1- (2- (4- (4- fluoro- benzoyl)- piperidin- 1- yl)- ethyl)- 3,3- dimethyl- 1,2- dihydro- indol- 2- oneIBA 05/2022
1	Cholinergic Agents (Cholinergics)IBA 05/2022
1	L 694247IBA 05/2022
1	Urea (Carbamide)FDA LinkGeneric 03/2022
1	NitrogenIBA 03/2022
1	CreatinineIBA 03/2022